Earnings Call · Q4 FY2024·2025-03-31

Q4 24EPS -3.85%·Rev n/aQ3 24EPS +17.24%·Rev n/aQ2 24EPS +10.34%·Rev n/aQ1 24EPS -26.09%·Rev n/a⚠ consensus missing

Rani Therapeutics Holdings, Inc. RANI

Kiki Patel — Investor Relations

Talat Imran — Chief Executive Officer

Svai Sanford — Chief Financial Officer

−2.4%1d on move date−2.7% vs SPY3d+3.2%5d−11.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RANI calls or request research access.

More RANI calls Browse calls Request research access